Abstract The present study was carried out to evaluate the occurrence of association between homocysteine, folic acid and vitamin B 12 in patients with preeclampsia. Fifty preeclamptic patients from gynecology ward were studied for estimation of serum homocysteine, folic acid and vitamin B 12 over a period of October 2007 to June 2010. Serum homocysteine and folic acid, and vitamin B 12 were determined by means of Immulite 1000 analyzer. The statistical analysis of study group of preeclampsia compared with normotensive control group, showed significant alterations in serum homocysteine, folic acid and vitamin B 12 concentrations in preeclampsia. Inverse association between serum homocysteine and folic acid, and vitamin B 12 levels were observed in preeclampsia. The present study found hyperhomocysteinemia and deficiency of folic acid and vitamin B 12 along with increased blood pressure as a risk factor for cardiovascular disease (CVD) in preeclampsia.
Introduction
Pregnancy induced hypertension may occur in about 3-10% of all pregnancies [1, 2] . It remain a major cause of perinatal and maternal morbidity and mortality world-wide, because of complications such as pre-eclampsia, eclampsia, fetal growth retardation, premature birth or abruptio placentae [3] .
An increased concentration of total circulating homocysteine in serum is recognized as an independent risk factor for cardiovascular diseases (CVD) [4, 5] . Moreover, determinants of hyperhomocysteinemia, such as low concentrations of folic acid and vitamin B 12 involved in homocysteine metabolism are also associated with increased risk of vascular damage [6] [7] [8] . It is uncertain whether hyperhomocysteinemia per se or low concentrations of vitamin B 12 and folic acid are atherogenic factors that trigger vascular disease. The present study undertaken to determine the levels of serum homocysteine, folic acid and vitamin B 12 and their correlationship in patients with preeclampsia.
Materials and Methods
This study was carried out at Department of Biochemistry, Grant Medical College and Sir J.J. Group of Government Hospitals, Mumbai. All participants completed a medical history form and provided informed consent. Fifty preeclamptic patients in the age group of 18-35 years were studied for estimation of serum total homocysteine, folic acid, and vitamin B 12 over a period of January 2008 to June 2010. Control group consist of 50 healthy normotensive pregnant subjects of identical age without any disease were enrolled.
Inclusion Criteria
Patients with symptoms and signs suggestive of eclampsia supported by laboratory investigations. And with normal renal and liver function tests were included in the study.
Exclusion Criteria
Patients having use of medications (therapy involving S-adenosyl-methionine, carbamazepine, phenytoin, 6-azauridine, xanthopterin, antifolic acids, anticonvulsant agents, tamoxifen, and theophylline), cancer, anemia, systemic illness and those with major illness were excluded from study. The Institutional Ethical Committee at the Grant Medical College and Sir J.J. Group of Government Hospitals, Mumbai, India, approved the study.
Blood Sample Collection
Venous blood samples were collected in test tube with aseptic precautions. After 2 h of collections sample was centrifuged at 3000 rpm for 5 min. Serum was separated and collected in polythene tube with cork. The sera with no sign of hemolysis used for the analysis of total circulating homocysteine, folic acid, vitamin B 12 and thyroid function.
Biochemical Analysis
Serum homocysteine concentration was measured by competitive chemiluminescent enzyme immunoassay method [9] . Serum folic acid concentration was investigated by boil competitive, liquid phase, ligand labeled, and protein binding chemiluminescent assay method [10] . Serum vitamin B 12 concentration was evaluated by solid phase, competitive chemiluminescent assay method [11] . We used fully automated enzyme amplified chemiluminescent immuno assay based Immulite 1000 analyzer. Measurement of these blood parameters by using commercial kits from Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA. Hyperhomocysteinemia was defined as a serum homocysteine concentration greater than 16 lmol/l.
Statistical Analysis
Numerical variables were reported in terms of mean and standard deviation. Statistical analysis of results was done by normal distribution 'Z' test. In this analysis, variables showing P-value less than 0.05 and 0.001 were considered to be statistically significant and highly significant, respectively. Pearson correlation test was used to test correlation.
Results
Demographic data of preeclamptic patients such as mean age of preeclampsia patients was showed significant fall (P \ 0.05) whereas body mass index (BMI), systolic blood pressure (SBP) and diastolic blood pressure (DBP) are highly significant increase (P \ 0.001) as compared with control group (Table 1) . Table 2 depicts changes in serum profile when control group was compared with study group of preeclampsia. As can be seen, significant increase (P \ 0.001) were observed in serum homocysteine whereas, folic acid and vitamin B 12 levels showed significant decrease (P \ 0.001).
A negative and significant correlation was observed between serum homocysteine compared with vitamin B 12 whereas an inverse and insignificant relationship was found between serum homocysteine and folic acid in preeclampsia. (Table 3) . 
Discussion
Our finding suggests that levels of serum homocysteine, folic acid and vitamin B 12 are altered in preeclampsia patients than in age-matched normotensive pregnant control subjects. In preeclampsia patients, weight, BMI, SBP and DBP MBP showed significant increase. Importance of these parameters has been recognized estimating cardiovascular disease risk factor due to their positive association with hypertension [12] . The present study shows that there was significant hyperhomocysteinemia and deficiency of folic acid and vitamin B 12 patients with preeclampsia. Hyperhomocysteinemia in such preeclamptic patients were found in our study might be due to modulation in homocysteine metabolism, which corroborates with the work of Walker et al. [13] , Hogg et al. [14] , Vollset et al. [15] . About more than one-half of the cases (54%) had hyperhomocysteinemia in study group of preeclamptic patients in our study. These prospective studies with rather small cohorts of patients with preeclampsia have shown an independent association between elevated serum homocysteine level and cardiovascular complications.
Several factors may increase homocysteine levels in women with preeclampsia. Metabolism in the kidney is the major route by which homocysteine is cleared from plasma and this route of elimination may be affected by preeclamptic changes in the kidney [16] . Several studies have demonstrated serum concentrations of homocysteine increases in preeclampsia [13] [14] [15] . These studies support our results.
In our study, the levels of vitamins B 12 and folic acid were significantly lowered in the preeclamptic as compared to control groups suggesting that there were the vitamin deficiencies. Carmel R found that differences in folic acid concentrations between preeclamptic and normal pregnant women [17] . Similarly, in a systematic review by Mignini et al., folic acid and vitamin B 12 concentrations were lower in preeclamptic women when compared with those of normotensive women [18] . In another study, there was no difference in folic acid and vitamin B 12 levels between pooled normal and preeclamptic groups but these levels were significantly lower in patients with the 677 CT mutation of MTHFR [19] .
The serum homocysteine was found to have negative and insignificant correlation with serum folic acid in preeclamptic patients. Their correlation coefficient (r) of -0.196 (P = 0.174) and 95% CI of 'r' ranged from -0.449 to ?0.088 (Fig. 1) . A good, negative and statistically significant correlation (r = -0.335 and P \ 0.05) was found between serum homocysteine and vitamin B 12 in preeclampsia. Their 95% CI of 'r' ranged from -0.561 to -0.062 (Fig. 2) . In present literature, there are two pathways by which homocysteine metabolized: remethylation and transsulfuration. Folic acid and vitamin B 12 are required for the remethylation of homocysteine to methionine; vitamin B 6 is required for the transsulfuration of homocysteine to cysteine [20] . A good correlation between serum homocysteine and folic acid, and vitamin B 12 levels observed in our study support this view.
From the above discussion we can assume that biochemical screening such as homocysteine, folic acid, vitamin B 12 are of paramount importance in preeclampsia. The inverse relation between homocysteine and folic acid, and vitamin B 12 indicates that severity associated with metabolic disturbances in preeclampsia that can be contributed to CVD. On the other hand, there is an absolute need for large studies designed to answer the question as to whether hyperhomocysteinemia and vitamin B deficiency are associated with increased risk for CVD and whether therapy of these disorders might influence cardiovascular mortality. Further studies should help define the role of genetic 
